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Summary Cigarette smoking is associated with a reduction in the risk for endometrial cancer in post-
menopausal women and it has been suggested that this is because smoking has an anti-oestrogenic effect. To
investigate this, concentrations of oestrone, oestradiol and oestriol were measured in 24 h urine samples from
167 premenopausal women (53 smokers, 114 non-smokers) and 200 post-menopausal women (54 smokers, 146
non-smokers). Among premenopausal women there were no significant differences in oestrogen excretion
between smokers and non-smokers. Among post-menopausal women, geometric mean excretion rates for
oestrone and oestradiol did not differ significantly between groups, but oestriol excretion was 19% lower (95%
confidence interval - 34% to -1 %) in smokers than in non-smokers. This may partly explain the reduced risk
for endometrial cancer among post-menopausal smokers.
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In comparison with non-smokers, women who smoke have a
lower risk of post-menopausal endometrial cancer, an earlier
menopause and a higher incidence of osteoporosis, and it has
been suggested that all these associations are consequences of
an anti-oestrogenic effect of cigarette smoking (Baron, 1984).
The protective effect against post-menopausal endometrial
cancer is substantial; for example, in a large population-based
case-control study, Brinton et al. (1993) reported a relative
risk of 0.4 in current smokers vs never smokers. Although
this finding is of no direct value in preventing endometrial
cancer, understanding of the mechanism involved is
important and a number of studies have therefore
investigated the association of cigarette smoking with sex
hormones.
MacMahon et al. (1982) reported that premenopausal
women smokers have reduced urinary excretion of oestrone,
oestradiol and oestriol in the luteal phase (but not in the
follicular phase) of the menstrual cycle and suggested that
this might be caused by reduced oestrogen production.
Subsequent investigations have shown that the relationship
of cigarette smoking with steroid hormones is complex.
Several studies have reported that smoking increases adrenal
activity, resulting in increased serum concentrations of
androstenedione and dehydroepiandrosterone sulphate, and
of progesterone in post-menopausal women (and in the early
follicular phase) (Friedman et al., 1987; Schlemmer et al.,
1990; Zumoff et al., 1990; Cassidenti et al., 1992). Smoking is
not associated with serum concentrations of endogenous
oestradiol among premenopausal or post-menopausal women
(Friedman et al., 1987; Khaw et al., 1988; Longcope and
Johnston, 1988; Cauley et al., 1989; Zumoff et al., 1990; Key
et al., 1991; Berta et al., 1992; Cassidenti et al., 1992; Daniel
et al., 1992). These results suggest that the protective effect of
smoking might be due to the increase in androgens and/or
progesterone rather than due to a reduction in oestrogen
exposure, although other investigations suggest that smoking
does alter the metabolism of oestradiol. Serum concentrations
of oestradiol are lower in smokers than in non-smokers
among post-menopausal women taking oral oestrogen
replacement therapy (Jensen et al., 1985), and Michnovicz
et al. (1986, 1988) reported that the proportion of estradiol
metabolised by 2-hydroxylation is significantly higher in
premenopausal women who smoke than in non-smokers and
is accompanied by increased excretion of 2-hydroxyoestrone
and decreased excretion of oestriol. Michnovicz et al. (1986,
1988) suggested that this decrease in the proportion of
oestradiol catabolised to oestriol and increase in the
proportion catabolised to 2-hydroxyoestrone would cause a
net reduction in oestrogenic stimulation and could, therefore,
explain the protective effect of smoking against endometrial
cancer. However, other studies have failed to find significant
differences in urinary oestrogen excretion between smokers
and non-smokers among either premenopausal or post-
menopausal women (Trichopoulos et al., 1987; Berta et al.,
1992). The purpose of the current study was to re-examine
the possible association of cigarette smoking with urinary
oestrogen excretion and, in particular, to test the hypothesis
that smoking is associated with a reduction in the excretion
of oestriol (Michnovicz et al., 1988). We were unable to test
the hypothesis of increased excretion of 2-hydroxyoestrone in
smokers because our assay for this catecholoestrogen was not
sufficiently sensitive.
Materials and methods
Subjects
Between 1977 and 1984, approximately 5000 women aged 34
years and above were recruited into a prospective study of
hormones and breast cancer in Guernsey. Height and weight
were measured and a questionnaire was completed at
interview with details of reproductive history, menopausal
status and use of oral contraceptives and hormone
replacement therapy. A 24 h urine sample was also
collected. In premenopausal women this sample was
collected irrebspective of the stage of the menstrual cycle,
but the dates of onset of menses preceding and following
urine collection were recorded. A questionnaire on cigarette
smoking was completed by approximately the first 1000
women, recruited between March 1977 and November 1978.
The samples selected for assay of urinary oestrogens were
those for all women who were current smokers, were not
using exogenous sex hormones, and were either premeno-
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pausal or post-menopausal (natural menopause or bilateral
ovariectomy). For premenopausal women, an additional
selection criterion was that urine samples had been collected
either between 3 and 11 days after the onset of the last
menstruation (follicular phase) or between 11 and 3 days
before the onset of the next menstruation (luteal phase).
Samples for comparison were from women who were known
to be non-smokers at recruitment but who met the other
criteria, randomly sampled to give a ratio of non-smokers to
smokers of approximately 2 to 1 among premenopausal
women and approximately 3 to 1 among post-menopausal
women.
Assays
Urine samples were considered to be incomplete if the 24 h
urine volume was less than or equal to 633 ml, the lower limit
of the 95% reference interval in 51 women studied by
Bingham et al. (1988). Aliquots of urine, identified by code
numbers, were sent frozen to the University of Melbourne,
where urinary concentrations of oestrone, oestradiol and
oestriol were measured during 1989 and 1990 using a method
involving spectrophotofluorimetry and internal radioactive
standards (Brown, 1976). Assay variation was assessed by
including one quality control sample in each run of 12
samples. The mean values and coefficients of variation for
this sample were: oestrone 9.8 jg I-', 11%; oestradiol
3.7 ,ug 11, 17%; oestriol 7.2 pg 1-', 14%. These coefficients
of variation incorporate both within-assay and between-assay
variability. Daily oestrogen excretion was calculated from the
concentration in the urine and the volume of urine collected.
The sensitivity of the method was sufficient to estimate
concentrations as low as 0.1 ,ug 11, and no samples were
below this limit.
To assess whether there was evidence for deterioration of
the samples with long-term storage, we examined the
association of total oestrogen excretion (oes-
trone +oestradiol +oestriol) with the year of urine collection
in these samples plus other samples from the same cohort,
which were collected later and were assayed for analysis in a
nested case-control study of oestrogen excretion and breast
cancer risk (Key et al., 1996). There was a statistically
significant trend of higher oestrogen excretion in the more
recently collected samples, with estimated increases of 6.6%
per year and 7.8% per year between 1977 and 1984 in
premenopausal and post-menopausal women respectively.
This effect will not influence the comparison of smokers
with non-smokers because all the samples (smokers and non-
smokers) were collected between March 1977 and November
1978 and all the assays were conducted, with samples in
arbitrary order, during 1989 and 1990, so that differences in
storage time between smokers and non-smokers are minimal.
Statistical analysis
Oestrogen excretion rates were logarithmically transformed to
produce approximately normal distributions. Mean oestrogen
values presented are geometric means, adjusted by analysis of
covariance for age (years) and Quetelet's index (kg m-2) and,
among premenopausal women where stated, for stage of
menstrual cycle using three indicator variables to specify 3-7
and 8 -11 days from the beginning ofthe cycle (early and late
follicular) and 11-8 and 7-3 days from the end of the cycle
(early and late luteal). To summarise the differences between
smokers and non-smokers, we calculated the geometric means
(and 95% confidence intervals) of the ratios of the variables
as an estimate of the percentage differences between the two
groups.
Results
Subject characteristics
Among premenopausal women, smokers were on average 0.9
years younger and 0.5 kg m-2 thinner than non-smokers
(Table I). Among post-menopausal women, smokers were on
average 2.1 years younger, 0.8 years younger at menopause,
and 0.3 kg m-2 thinnner than non-smokers (Table I).
Table I Characteristics of non-smokers and smokers
Non-smokers Smokers
Variable Mean s.d. n Mean s.d. n pa
Premenopausal
Age (years) 42.4 4.0 114 41.5 4.8 53 0.226
Quetelet's 24.6 3.4 114 24.1 3.8 53 0.318
index (kg m-2)
Post-menopausal
Age (years) 57.9 6.3 146 55.8 6.4 54 0.042
Age at menopause 48.7 5.3 142 47.9 4.1 53 0.372
(years)
Quetelet's index 25.3 3.5 146 25.0 3.5 54 0.686
(kg m 2)
aTwo-sided test for difference between means.
Table II Oestrogen excretion and stage of menstrual cycle in premenopausal non-smokers and smokers
Non-smokers Smokers
Geometric Geometric
Cycle stage mean (95% CI) n mean (95% CI) n
Oestrone (jig 24 h-1)
Early follicular 4.61 (3.17-6.71) 14 5.33 (3.56-7.99) 12
Late follicular 7.33 (5.72-9.39) 32 7.59 (5.40-10.65) 17
Early luteal 7.60 (6.13-9.44) 42 7.57 (5.21-11.00) 14
Late luteal 7.78 (5.91-10.24) 26 8.93 (5.74-13.91) 10
Oestradiol (,ug 24 h-1)
Early follicular 2.39 (1.64-3.48) 14 2.61 (1.74-3.93) 12
Late follicular 3.69 (2.88-4.74) 32 3.86 (2.74-5.43) 17
Early luteal 3.89 (3.13-4.84) 42 4.04 (2.77-5.89) 14
Late luteal 3.72 (2.82-4.91) 26 4.27 (2.73-6.67) 10
Oestriol (jg 24 h-')
Early follicular 4.06 (2.66-6.21) 14 5.28 (3.35-8.35) 12
Late follicular 7.11 (5.38-9.41) 32 6.79 (4.63-9.97) 17
Early luteal 11.78 (9.22-15.03) 42 9.14 (5.99-13.96) 14
Late luteal 12.11 (8.88-16.51) 26 9.80 (5.94-16.16) 10
Geometric mean values are adjusted for age (years) and Quetelet's index (kg m-2).s-on umy ogen
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Table III Oestrogen excretion and amount smoked in premenopausal women
Difference ofsmokers
from non-smokers
Non smokers 1-10 cigarettes 11 - cigarettes All smokers (95% confidence
Oestrogen (n=114) per day (n=17) per day (n=36) (n=53) interval)
Oestrone (pg 24 h-1) 7.00 7.05 7.67 7.46 -7% (-15% to +34%)
Oestradiol (,ug 24 h-1) 3.52 3.79 3.76 3.77 -7% (-15% to +35%)
Oestriol (jig 24 h-1) 8.73 7.60 8.22 8.02 - 8% (-29% to + 19%)
Values are geometric means. adjusted for age (years). Quetelet's index (kg m-2 and stage ofcycle (early follicular.
late follicular. early luteal. late luteal).
Table IV Oestrogen excretion and amount smoked in post-menopausal women
Difference ofsmokers
from non-smokers
Non smokers 1-10 cigarettes 11 - cigarettes All smokers (95% confdence
Oestrogen mn=146} per day (n=26} per day (n=28} (n=54} interval)
Oestrone (jug 24 h-1) 1.39 1.17 1.45 1.31 - 6% (-21% to + 12/%)
Oestradiol (jig 24 h-') 0.68 0.67 0.70 0.69 +1% (-15% to +20%)
Oestriol (pg 24 h-I) 1.57 1.32 1.22 1.27 - 19% (-34% to -1%)
Values are geometric means. adjusted for age (years). Quetelet's index (kg m-2).
Oestrogen excretion in premenopausal women
Table II shows geometric mean urinary oestrogen excretion
in non-smokers and smokers, grouped according to the stage
of the menstrual cycle at which urine was collected.
Oestrogen excretion increased from the early follicular phase
to the luteal phase. Geometric mean excretion of oestrone
was 0- 16% higher in smokers than in non-smokers, and
geometric mean excretion of oestradiol was 4-15% higher in
smokers than in non-smokers. Geometric mean excretion of
oestriol was 30% higher in smokers than in non-smokers in
the early follicular phase. but 5-22% lower in smokers in the
later stages of the cycle.
Table III shows geometric mean oestrogen excretion both
by amount smoked and for all smokers, after adjusting for
stage of cycle. There were no significant differences in
oestrogen excretion between smokers and non-smokers.
Oestrogen excretion in post-menopausal women
Adjusted geometric mean excretion rates for oestrone and
oestradiol did not differ significantly between smokers and
non-smokers. Geometric mean excretion of oestriol was 19%
lower (95% confidence interval 34% to 1% lower) in smokers
than in non-smokers (Table IV).
smokers than non-smokers. This change could be caused by
increased catabolism of oestradiol through the alternative 2-
hydroxylation pathway. as suggested by Michnovicz et al.
(1986, 1988) from their study in premenopausal women, and
might partly explain the protective effect of smoking against
endometrial cancer. Trichopoulos et al. (1987). however.
reported no difference in oestriol excretion between post-
menopausal smokers and non-smokers (mean difference
between smokers and non-smokers +6%. 90% confidence
interval -8% to +22%). but no information on the number
of cigarettes smoked was given in this study.
We did not find any statistically significant differences in
oestrogen excretion between smokers and non-smokers
among premenopausal women. although there was a small
(8%) reduction in oestriol excretion in smokers. MacMahon
et al. (1982) reported similar excretion rates of oestrone.
oestradiol and oestriol in smokers and non-smokers in the
follicular phase, but about 30% lower excretion of all three
oestrogens in smokers in the luteal phase, whereas
Michnovicz et al. (1988) reported 31% lower excretion of
oestriol in the follicular phase. However. in a large recent
study. Berta et al. (1992) found no difference between
smokers and non-smokers in luteal phase excretion of
oestrone. oestradiol or oestriol. Overall, therefore. it is
unclear whether smoking has an important effect on
oestrogen excretion in premenopausal women.
Discussion
Epidemiiological studies have established that cigarette
smoking reduces the nrsk of endometnral cancer in post-
menopausal women. and investigation of the possible
mechanism for this effect should increase our understanding
of the aetiology of this disease. In the current study, the only
statistically significant difference between study groups was
the 19% lower excretion of oestriol in post-menopausal
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